Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis

Medicine & Life Sciences

• Tropical Spastic Paraparesis 100%
• T-Cell Leukemia 93%
• Spinal Cord Diseases 78%
• Human T-lymphotropic virus 1 66%
• Central Nervous System 50%
• Cytotoxic T-Lymphocytes 24%
• Virus Diseases 16%
• Nervous System Diseases 14%
• T-Lymphocytes 14%
• Human T-lymphotrophic virus 1 tax protein 14%
• Adult T Cell Leukemia Lymphoma 9%
• Patient Transfer 9%
• Immunologic Factors 8%
• Lymphocyte Activation 8%
• Dendritic Cells 6%
• Monocytes 6%
• Population 5%
• Macrophages 5%
• Viruses 5%
• Pathology 4%